Movement Disorders in Psychiatry
Herausgeber: Teixeira, Antonio; Ondo, William G; Furr Stimming, Erin
Movement Disorders in Psychiatry
Herausgeber: Teixeira, Antonio; Ondo, William G; Furr Stimming, Erin
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Movement Disorders in Psychiatry offers an in-depth perspective on movement disorders with treatment and practical management strategies for related challenges in clinical practice.
Andere Kunden interessierten sich auch für
- Agnes WongEye Movement Disorders [With CDROM]56,99 €
- Movement Disorders86,99 €
- Kailash P BhatiaCase Studies in Movement Disorders87,99 €
- Movement Disorders and Inherited Metabolic Disorders195,99 €
- A Practical Approach to Movement Disorders81,99 €
- David SugdenMovement Difficulties in Developmental Disorders63,99 €
- Ramzy Yassa / N. P. V. Nair / Dilip V. Jeste (eds.)Neuroleptic-Induced Movement Disorders137,99 €
-
-
-
Movement Disorders in Psychiatry offers an in-depth perspective on movement disorders with treatment and practical management strategies for related challenges in clinical practice.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Hurst & Co.
- Seitenzahl: 448
- Erscheinungstermin: 18. November 2022
- Englisch
- Abmessung: 256mm x 177mm x 24mm
- Gewicht: 798g
- ISBN-13: 9780197574317
- ISBN-10: 0197574319
- Artikelnr.: 66135907
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
- Verlag: Hurst & Co.
- Seitenzahl: 448
- Erscheinungstermin: 18. November 2022
- Englisch
- Abmessung: 256mm x 177mm x 24mm
- Gewicht: 798g
- ISBN-13: 9780197574317
- ISBN-10: 0197574319
- Artikelnr.: 66135907
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
Antonio L. Teixeira, MD, PhD, MSc, is Professor of Psychiatry and Neurology at University of Texas Health Houston where he leads the Neuropsychiatry Program. Dr. Teixeira is involved in research and clinical care of behavioral disorders in patients with Huntington's disease, Parkinson's disease, and other neurodegenerative diseases. Erin Furr Stimming, MD, is Professor of Neurology and founding Director of the Huntington's Disease Society of America Center of Excellence at University of Texas Health Houston. Dr. Furr Stimming is Fellow of the American Academy of Neurology and Director of the Neurology clerkship at McGovern Medical School. She devotes her time to clinical care and research for individuals with Huntington's disease, Parkinson's disease, and other movement disorders in addition to educating future physicians. William G. Ondo, MD, is Director of the Movement Disorder Clinic at Houston Methodist Hospital and Professor of Neurology at Weill Cornell Medical School and Texas A&M. Dr. Ondo has served as primary, treating, and sub-investigator for many research projects involving adult and pediatric movement disorder research.
* Table of Contents
* Preface
* Part I: Movement Disorders Overview
* Chapter 1: Introduction to the Movement Disorders: Definition and
Clinical Phenotypes
* Erin Furr-Stimming, Jorge Patino Murillas, and William G. Ondo
* Chapter 2: Pathophysiology of Primary and Secondary Movement
Disorders
* Claudio Da Cunha, William Sánchez-Luna, Fernando Henrique Teixeira
Zonzini, Daniel R. Benke, and José Augusto Pochapski
* Part II: Movement Disorders Associated with Psychotropics
* Chapter 3: Dopamine Antagonist-Induced Parkinsonism
* Abdulmunaim M. Eid and William G. Ondo
* Chapter 4: Akathisia
* Satyajit Mohite, Ossama T. Osman, Lokesh Shahani, and Antonio L.
Teixeira
* Chapter 5: Tardive Dyskinesia
* Vinicius Sousa Pietra Pedroso, João Vinícius Salgado, and Antonio L.
Teixeira
* Chapter 6: Serotonin Syndrome and Neuroleptic Malignant Syndrome
* Haitham Salem, Brittany Finocchio, and Teresa Pigott
* Chapter 7: Movement Disorders Associated with SSRIs
* Jennifer G. Goldman and Carlos Manuel Guerra Galicia
* Chapter 8: The Under Recognized Movement Disorders Associated with
Mood Stabilizers: Lithium, Valproate, Carbamazepine, Lamotrigine
* Melody Badii and William G. Ondo
* Chapter 9: Movement Disorders Associated with Stimulants and Other
Drugs of Abuse
* Luiz Paulo Vasconcelos, Jordi Gandini, Antonio L. Teixeira, and Mario
Manto
* Part III: Movement Disorders Seen in Primary Psychiatric Disorders
* Chapter 10: Neurological Soft Signs in Schizophrenia Spectrum
Disorders
* Johannes Schröder and Christina J. Herold
* Chapter 11: Stereotypies in Childhood Developmental Disorders and
Neurodegenerative Diseases
* Joohi Jimenez-Shahed
* Chapter 12: Catatonia and Hypokinetic Movement Disorders
* Nidaullah Mian, Carla Bejjani, and Raja Mehanna
* Chapter 13: Functional Movement Disorders
* Jennifer S. Sharma and Alberto J. Espay
* Part IV: Diseases with Concurrent Psychiatric and Movement Disorders
Symptoms
* Chapter 14: Tics and Tourette Syndrome
* Abhishek Lenka and Joseph Jankovic
* Chapter 15: Huntington's Disease
* Natalia Pessoa Rocha, Andy Liu, Karen Anderson, and Erin
Furr-Stimming
* Chapter 16: Behavioral Abnormalities in Other Genetic and Non-Genetic
Causes of Chorea
* Ricardo Maciel, Débora Palma Maia, and Francisco Cardoso
* Chapter 17: Parkinson's Disease and Atypical Parkinsonian Syndromes
* Julia Ridgeway-Diaz and Laura Marsh
* Chapter 18: Frontotemporal Dementia: Symptoms, Distinguishing
Features, Genetics, Pathology, and Associated Movement Disorders
* Albert Y. Amran, Avram S. Bukhbinder, and Paul E. Schulz
* Chapter 19: Restless Legs Syndrome and Psychiatric Issues
* Emmanuel H. During and John W. Winkelman
* Chapter 20: Neurometabolic Diseases
* Nivedita Thakur, Moira Black, Sam Nicholas Russo, and Mary Kay Koenig
* Chapter 21: Autoimmune and Paraneoplastic Encephalopathies
* James F. Rini, Bradley T. Peet, and Michael D. Geschwind
* Preface
* Part I: Movement Disorders Overview
* Chapter 1: Introduction to the Movement Disorders: Definition and
Clinical Phenotypes
* Erin Furr-Stimming, Jorge Patino Murillas, and William G. Ondo
* Chapter 2: Pathophysiology of Primary and Secondary Movement
Disorders
* Claudio Da Cunha, William Sánchez-Luna, Fernando Henrique Teixeira
Zonzini, Daniel R. Benke, and José Augusto Pochapski
* Part II: Movement Disorders Associated with Psychotropics
* Chapter 3: Dopamine Antagonist-Induced Parkinsonism
* Abdulmunaim M. Eid and William G. Ondo
* Chapter 4: Akathisia
* Satyajit Mohite, Ossama T. Osman, Lokesh Shahani, and Antonio L.
Teixeira
* Chapter 5: Tardive Dyskinesia
* Vinicius Sousa Pietra Pedroso, João Vinícius Salgado, and Antonio L.
Teixeira
* Chapter 6: Serotonin Syndrome and Neuroleptic Malignant Syndrome
* Haitham Salem, Brittany Finocchio, and Teresa Pigott
* Chapter 7: Movement Disorders Associated with SSRIs
* Jennifer G. Goldman and Carlos Manuel Guerra Galicia
* Chapter 8: The Under Recognized Movement Disorders Associated with
Mood Stabilizers: Lithium, Valproate, Carbamazepine, Lamotrigine
* Melody Badii and William G. Ondo
* Chapter 9: Movement Disorders Associated with Stimulants and Other
Drugs of Abuse
* Luiz Paulo Vasconcelos, Jordi Gandini, Antonio L. Teixeira, and Mario
Manto
* Part III: Movement Disorders Seen in Primary Psychiatric Disorders
* Chapter 10: Neurological Soft Signs in Schizophrenia Spectrum
Disorders
* Johannes Schröder and Christina J. Herold
* Chapter 11: Stereotypies in Childhood Developmental Disorders and
Neurodegenerative Diseases
* Joohi Jimenez-Shahed
* Chapter 12: Catatonia and Hypokinetic Movement Disorders
* Nidaullah Mian, Carla Bejjani, and Raja Mehanna
* Chapter 13: Functional Movement Disorders
* Jennifer S. Sharma and Alberto J. Espay
* Part IV: Diseases with Concurrent Psychiatric and Movement Disorders
Symptoms
* Chapter 14: Tics and Tourette Syndrome
* Abhishek Lenka and Joseph Jankovic
* Chapter 15: Huntington's Disease
* Natalia Pessoa Rocha, Andy Liu, Karen Anderson, and Erin
Furr-Stimming
* Chapter 16: Behavioral Abnormalities in Other Genetic and Non-Genetic
Causes of Chorea
* Ricardo Maciel, Débora Palma Maia, and Francisco Cardoso
* Chapter 17: Parkinson's Disease and Atypical Parkinsonian Syndromes
* Julia Ridgeway-Diaz and Laura Marsh
* Chapter 18: Frontotemporal Dementia: Symptoms, Distinguishing
Features, Genetics, Pathology, and Associated Movement Disorders
* Albert Y. Amran, Avram S. Bukhbinder, and Paul E. Schulz
* Chapter 19: Restless Legs Syndrome and Psychiatric Issues
* Emmanuel H. During and John W. Winkelman
* Chapter 20: Neurometabolic Diseases
* Nivedita Thakur, Moira Black, Sam Nicholas Russo, and Mary Kay Koenig
* Chapter 21: Autoimmune and Paraneoplastic Encephalopathies
* James F. Rini, Bradley T. Peet, and Michael D. Geschwind
* Table of Contents
* Preface
* Part I: Movement Disorders Overview
* Chapter 1: Introduction to the Movement Disorders: Definition and
Clinical Phenotypes
* Erin Furr-Stimming, Jorge Patino Murillas, and William G. Ondo
* Chapter 2: Pathophysiology of Primary and Secondary Movement
Disorders
* Claudio Da Cunha, William Sánchez-Luna, Fernando Henrique Teixeira
Zonzini, Daniel R. Benke, and José Augusto Pochapski
* Part II: Movement Disorders Associated with Psychotropics
* Chapter 3: Dopamine Antagonist-Induced Parkinsonism
* Abdulmunaim M. Eid and William G. Ondo
* Chapter 4: Akathisia
* Satyajit Mohite, Ossama T. Osman, Lokesh Shahani, and Antonio L.
Teixeira
* Chapter 5: Tardive Dyskinesia
* Vinicius Sousa Pietra Pedroso, João Vinícius Salgado, and Antonio L.
Teixeira
* Chapter 6: Serotonin Syndrome and Neuroleptic Malignant Syndrome
* Haitham Salem, Brittany Finocchio, and Teresa Pigott
* Chapter 7: Movement Disorders Associated with SSRIs
* Jennifer G. Goldman and Carlos Manuel Guerra Galicia
* Chapter 8: The Under Recognized Movement Disorders Associated with
Mood Stabilizers: Lithium, Valproate, Carbamazepine, Lamotrigine
* Melody Badii and William G. Ondo
* Chapter 9: Movement Disorders Associated with Stimulants and Other
Drugs of Abuse
* Luiz Paulo Vasconcelos, Jordi Gandini, Antonio L. Teixeira, and Mario
Manto
* Part III: Movement Disorders Seen in Primary Psychiatric Disorders
* Chapter 10: Neurological Soft Signs in Schizophrenia Spectrum
Disorders
* Johannes Schröder and Christina J. Herold
* Chapter 11: Stereotypies in Childhood Developmental Disorders and
Neurodegenerative Diseases
* Joohi Jimenez-Shahed
* Chapter 12: Catatonia and Hypokinetic Movement Disorders
* Nidaullah Mian, Carla Bejjani, and Raja Mehanna
* Chapter 13: Functional Movement Disorders
* Jennifer S. Sharma and Alberto J. Espay
* Part IV: Diseases with Concurrent Psychiatric and Movement Disorders
Symptoms
* Chapter 14: Tics and Tourette Syndrome
* Abhishek Lenka and Joseph Jankovic
* Chapter 15: Huntington's Disease
* Natalia Pessoa Rocha, Andy Liu, Karen Anderson, and Erin
Furr-Stimming
* Chapter 16: Behavioral Abnormalities in Other Genetic and Non-Genetic
Causes of Chorea
* Ricardo Maciel, Débora Palma Maia, and Francisco Cardoso
* Chapter 17: Parkinson's Disease and Atypical Parkinsonian Syndromes
* Julia Ridgeway-Diaz and Laura Marsh
* Chapter 18: Frontotemporal Dementia: Symptoms, Distinguishing
Features, Genetics, Pathology, and Associated Movement Disorders
* Albert Y. Amran, Avram S. Bukhbinder, and Paul E. Schulz
* Chapter 19: Restless Legs Syndrome and Psychiatric Issues
* Emmanuel H. During and John W. Winkelman
* Chapter 20: Neurometabolic Diseases
* Nivedita Thakur, Moira Black, Sam Nicholas Russo, and Mary Kay Koenig
* Chapter 21: Autoimmune and Paraneoplastic Encephalopathies
* James F. Rini, Bradley T. Peet, and Michael D. Geschwind
* Preface
* Part I: Movement Disorders Overview
* Chapter 1: Introduction to the Movement Disorders: Definition and
Clinical Phenotypes
* Erin Furr-Stimming, Jorge Patino Murillas, and William G. Ondo
* Chapter 2: Pathophysiology of Primary and Secondary Movement
Disorders
* Claudio Da Cunha, William Sánchez-Luna, Fernando Henrique Teixeira
Zonzini, Daniel R. Benke, and José Augusto Pochapski
* Part II: Movement Disorders Associated with Psychotropics
* Chapter 3: Dopamine Antagonist-Induced Parkinsonism
* Abdulmunaim M. Eid and William G. Ondo
* Chapter 4: Akathisia
* Satyajit Mohite, Ossama T. Osman, Lokesh Shahani, and Antonio L.
Teixeira
* Chapter 5: Tardive Dyskinesia
* Vinicius Sousa Pietra Pedroso, João Vinícius Salgado, and Antonio L.
Teixeira
* Chapter 6: Serotonin Syndrome and Neuroleptic Malignant Syndrome
* Haitham Salem, Brittany Finocchio, and Teresa Pigott
* Chapter 7: Movement Disorders Associated with SSRIs
* Jennifer G. Goldman and Carlos Manuel Guerra Galicia
* Chapter 8: The Under Recognized Movement Disorders Associated with
Mood Stabilizers: Lithium, Valproate, Carbamazepine, Lamotrigine
* Melody Badii and William G. Ondo
* Chapter 9: Movement Disorders Associated with Stimulants and Other
Drugs of Abuse
* Luiz Paulo Vasconcelos, Jordi Gandini, Antonio L. Teixeira, and Mario
Manto
* Part III: Movement Disorders Seen in Primary Psychiatric Disorders
* Chapter 10: Neurological Soft Signs in Schizophrenia Spectrum
Disorders
* Johannes Schröder and Christina J. Herold
* Chapter 11: Stereotypies in Childhood Developmental Disorders and
Neurodegenerative Diseases
* Joohi Jimenez-Shahed
* Chapter 12: Catatonia and Hypokinetic Movement Disorders
* Nidaullah Mian, Carla Bejjani, and Raja Mehanna
* Chapter 13: Functional Movement Disorders
* Jennifer S. Sharma and Alberto J. Espay
* Part IV: Diseases with Concurrent Psychiatric and Movement Disorders
Symptoms
* Chapter 14: Tics and Tourette Syndrome
* Abhishek Lenka and Joseph Jankovic
* Chapter 15: Huntington's Disease
* Natalia Pessoa Rocha, Andy Liu, Karen Anderson, and Erin
Furr-Stimming
* Chapter 16: Behavioral Abnormalities in Other Genetic and Non-Genetic
Causes of Chorea
* Ricardo Maciel, Débora Palma Maia, and Francisco Cardoso
* Chapter 17: Parkinson's Disease and Atypical Parkinsonian Syndromes
* Julia Ridgeway-Diaz and Laura Marsh
* Chapter 18: Frontotemporal Dementia: Symptoms, Distinguishing
Features, Genetics, Pathology, and Associated Movement Disorders
* Albert Y. Amran, Avram S. Bukhbinder, and Paul E. Schulz
* Chapter 19: Restless Legs Syndrome and Psychiatric Issues
* Emmanuel H. During and John W. Winkelman
* Chapter 20: Neurometabolic Diseases
* Nivedita Thakur, Moira Black, Sam Nicholas Russo, and Mary Kay Koenig
* Chapter 21: Autoimmune and Paraneoplastic Encephalopathies
* James F. Rini, Bradley T. Peet, and Michael D. Geschwind